App-Quantinova.ai

AMP-activated Protein Kinase is Critical for Regulating Cholesterol Homeostasis in Macrophages

Sarka Lhotak - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

A-769662

Prevalence and Prognosis of Early Ischemic Moderate to Severe Mitral Regurgitation After Primary Percutaneous Coronary Intervention

Olivier F Bertrand - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Ischemic mitral regurgitation

N/A

Nocturnal Hemodialysis Restores Impaired Coronary Endothelial Function in End-Stage Renal Patients Receiving Conventional Hemodialysis

William Chan - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Microvascular complications of diabetes 1

Nitroglycerin

Effects of a Mutant Form of Atrial Natriuretic Peptide Associated With Atrial Fibrillation on Atrial Electrophysiology

Sarah MacLeod - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

Isoproterenol

Differential Atrial Regulation of Candidate mir-1, mir-133a and mir-328 in Patients Following On-Pump Coronary Artery Bypass Grafting

James Tsoporis - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

N/A

Does Aortic Resection without an Open Distal and Hemi-Arch Procedure Address all Regions at Risk of Progression in Bicuspid Aortopathy?

Pim van Ooij - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Severe Aortic Stenosis

N/A

Root Replacement versus More Conservative Management During Type A Acute Aortic Dissection Repair: Insights From the International Registry of Acute Aortic Dissection

Santi Trimarchi - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Aortic regurgitation

N/A

Impaired Parasympathetic Nervous System Regulation of the Sinoatrial Node in Type 1 Diabetes Mellitus

Emmanuel E Egom - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 1 diabetes mellitus

Acetylcholine

Prevalence, Characteristics, and Early Treatment Strategies of Patients with Chronic Total Occlusions Undergoing Coronary Computed Tomography Angiography

Briain o Hartaigh - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Chronic total occlusion

N/A

Calpain-2 Protects Against Doxorubicin-Induced Cardiac Toxicity

Rui Ni - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial Dysfunction

Doxorubicin

Weighing The Evidence: Geographic Variation And The Obesity Paradox In Patients With Acute Decompensated Heart Failure In The Ascend-hf Trial

Gretchen M Heizer - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute decompensated heart failure

Nesiritide

Post-dilatation and Procedural Outcomes in the PARTNER I Trial

Philippe Pibarot - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Paravalvular regurgitation

N/A

Does Prescriptive Exercise With Mobile Health Tracking Improve Self-efficacy and Health Status in Individuals With Metabolic Syndrome?

Dawn P Gill - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Metabolic syndrome

N/A

Risk Factors For 30-Day Outcome Following Multivessel Bypass Surgery in Diabetic Patients With Stable CAD: Pre-Operative Glycemic Control and Blood Pressure Management Matter

Sanjum S. Sethi - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Multi-vessel disease

N/A

Challenges of Anticoagulation during Cardiopulmonary Bypass in Children: Impact of Low Antithrombin Levels

Colleen E Gruenwald - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

Evithrom

Inhibition of CETP by Dalcetrapib Results in a Modest Increase in Cholesterol Efflux Capacity Associated With an Increase in Large HDL Particles, but Does Not Impact Carotid Intima-Media Thickness in a dal-PLAQUE-2 Substudy

Marie Boule - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Stable coronary artery disease

Dalcetrapib

Serum Parathyroid Hormone is Associated with Valvular Calcification but not with Aortic Root or Coronary Artery Calcification in Aortic Valve Stenosis

Romain Capoulade - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Complex calcified coronary artery lesions

Parathyroid hormone

Does a Repaired Type A Dissection Turn into a Medical Type B Dissection? Lessons From IRAD

Magnus Larsen - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

N/A

Physical Exercise Reduces Angiopoietin-like 2 Circulating Levels Only in CAD Patients With Endothelial Dysfunction

Doug Hayami - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Vasodilation dysfunction

Myoview

Effects of School-Based Interventions on Body Mass Index in Children and Adolescents: a Systematic Overview and Meta-analysis

Randa Bakhet - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Obesity

N/A

Filters

28841 Abstracts